EC Number   |
Title |
Organism |
|---|
   2.4.1.80 | UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells |
Homo sapiens |
| 2.4.1.80 | A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis |
Homo sapiens |
| 2.4.1.80 | A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis |
Mus musculus |
| 2.4.1.80 | A rapid and simple assay method for UDP-glucose:ceramide glucosyltransferase |
Rattus norvegicus |
| 2.4.1.80 | A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates |
Danio rerio |
| 2.4.1.80 | A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates |
Cricetulus griseus |
| 2.4.1.80 | A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase |
Homo sapiens |
| 2.4.1.80 | A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease |
Mus musculus |
| 2.4.1.80 | Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice |
Mus musculus |
| 2.4.1.80 | An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells |
Homo sapiens |
